Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery

Current Drug Targets

Volumn 12, Issue 11, 2011, Pages 1654-1673

  Chlipala, George E ^a   Mo, Shunyan ^a   Orjala, Jimmy ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antibacterial; Antifungal; Cyanobacteria; Cytotoxic; Protease inhibitor

Indexed keywords

AERUGINOSIN DERIVATIVE; ALKALOID DERIVATIVE; AMBIGUINE DERIVATIVE; ANABAENOPEPTIN DERIVATIVE; ANTIINFECTIVE AGENT; BRUNSVICAMIDE B; COMNOSTIN DERIVATIVE; CRYPTOPHYCIN DERIVATIVE; CYANOPEPTOLIN DERIVATIVE; CYTOTOXIN; FISCHERELLIN A; HAPALINDOLE DERIVATIVE; HASSALLIDIN A; MICROGININ DERIVATIVE; MICROVIRIDIN DERIVATIVE; NOSCOMIN; PEPTIDE DERIVATIVE; PROTEINASE INHIBITOR; SCYTOPHYCIN DERIVATIVE; SCYTOSCALAROL; TERPENOID DERIVATIVE; TJIPANAZOLE DERIVATIVE; TOLYTOXIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CYANOBACTERIUM; CYTOTOXICITY; DRUG STRUCTURE; FRESHWATER SPECIES; HUMAN; METABOLITE; NONHUMAN; REVIEW; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; TERRESTRIAL SPECIES;

BIODIVERSITY; CYANOBACTERIA; FRESH WATER;

EID: 80054098160     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011798109455     Document Type: Review

References (247)

1. Des Marais DJ. Evolution: when did photosynthesis emerge on earth? Science 2000; 289: 1703-5.
2. Schopf JW. In: Whitton BA, Potts M, Eds. The Ecology of Cyanobacteria. Their Diversity in Time and Space. Dordrecht, The Netherlands: Kluwer Academic Publishers 2000: 13-35.
3. Rao PV, Gupta N, Bhaskar AS, Jayaraj R. Toxins and bioactive compounds from cyanobacteria and their implications on human health. J Environ Biol 2002; 23: 215-224.
4. Dittmann E, Wiegand C. Cyanobacterial toxins--occurrence, biosynthesis and impact on human affairs. Mol Nutr Food Res 2006; 50: 7-17.
5. Shaw G, Lam PKS. Health aspects of freshwater cyanobacterial toxins. Water Sci. Technol. Water Supply 2007; 7: 193-203
6. Van Apeldoorn ME, Van Egmond HP, Speijers GJA, Bakker GJI. Toxins of cyanobacteria. Mol Nutr Food Res 2007; 51: 7-60
7. Welker M. In: Seafood and Freshwater Toxins; Botana LM, Ed. Boca Raton, FL, USA: CRC Press 2008: 825-843.
8. Gademann K, Portmann C. Secondary metabolites from cyanobacteria: complex structures and powerful bioactivities. Curr Org Chem 2008; 12: 326-341.
9. Fusetani N, Kem W. Marine toxins: an overview. Prog Mol Subcell Biol 2009; 46: 1-44.
10. Burja AM, Banaigs B, Abou-Mansour E, Burgess JG, Wright PC. Marine cyanobacteria - a prolific source of natural products. Tetrahedron 2001; 57: 9347-77.
11. König GM, Kehraus S, Seibert SF, Abdel-Lateff A, Mueller D. Natural products from marine organisms and their associated microbes. ChemBioChem 2006; 7: 229-238.
12. Proksch P, Edrada RA, Ebel R. Drugs from the seas: current status and microbiological implications. Appl Microbiol Biotechnol 2002; 59: 125-134.
13. Gerwick WH, Tan LT, Sitachitta N. In: The Alkaloids; Cordell GA, Ed. San Diego: Academic Press 2001; 57: 75-184.
14. Singh S, Kate BN, Banerjee UC. Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol 2005; 25: 73-95.
15. Sielaff H, Christiansen G, Schwecke T. Natrual products from cyanobacteria: exploiting a new source for drug discovery. IDrugs 2006; 9: 119-127.
16. Welker M, von Dohren H. Cyanobacterial peptides - nature's own combinatorial biosynthesis. FEMS Microbiol Rev 2006; 30: 530- 563.
17. Tan LT. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry 2007; 68: 954-979.
18. Schwartz RE, Hirsch CF, Sesin DF, et al. Pharmaceuticals from cultured algae. J Ind Microbiol 1990; 5: 113-123.
19. Smith CD, Zhang X, Mooberry SL, Patterson GML, Moore RE. Cryptophycin - a new antimicrotubule agent active against drug- resistant cells. Cancer Res 1994; 54: 3779-3784.
20. Smith CD, Zhang X. Mechanism of action cryptophycin. interaction with the vinca alkaloid domain of tubulin. J Biol Chem 1996; 271: 6192-6198.
21. Chaganty S, Golakoti T, Heltzel C, Moore RE, Yoshida WY. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224. J Nat Prod 2004; 67: 1403-1406.
22. Golakoti T, Ohtani I, Patterson GML, et al. Total structures of cryptophycins, potent antitumor depsipeptides from the blue-green- alga Nostoc sp. Strain GSV-224. J Am Chem Soc 1994; 116: 4729- 4737.
23. Golakoti T, Ogino J, Heltzel CE, et al. Structure determination, conformational-analysis, chemical-stability studies, and antitumor evaluation of the cryptophycins - isolation of 18 new analogs from Nostoc sp. Strain GSV-224. J Am Chem Soc. 1995; 117: 12030-1249
24. Wagner MM, Paul DC, Shih C, Jordan MA, Wilson L, Williams DC. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines. Cancer Chemother Pharmacol 1999; 43: 115-125.
25. Edelman MJ, Gandara DR, Hausner P, Israel V, Thornton D, DeSanto J, Doyle LA. Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer. Lung Cancer 2003; 39: 197-199.
26. D'Agostino G, Del Campo J, Mellado B, et al. A Multicenter phase ii study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. Int J Gynecol Cancer 2006; 16: 71-76.
27. Liang J, Moore RE, Moher ED, et al. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.Invest New Drugs 2005; 23: 213-224.
28. Magarvey NA, Beck ZQ, Golakoti T, et al. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. potent anticancer agents from cyanobionts. ACS Chem Biol 2006; 1: 766-779.
29. Beck ZQ, Aldrich CC, Magarvey NA, Georg GI, Sherman DH. Chemoenzymatic synthesis of cryptophycin/arenastatin natural products. Biochemistry 2005; 44: 13457-13466.
30. Ding Y, Seufert WH, Beck ZQ, Sherman DH. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity. J Am Chem Soc. 2008; 130: 5492-5498.
31. Carmeli S, Moore RE, Patterson GML. Tolytoxin and new scytophycins from three species of Scytonema. J Nat Prod 1990; 53: 1533-1542.
32. Jung JH, Moore RE, Patterson GML. Scytophycins from a blue- green alga belonging to the Nostocaceae. Phytochemistry 1991; 30: 3615-3616.
33. Smith CD, Carmeli S, Moore RE, Patterson GML. Scytophycins, novel microfilament-depolymerizing agents which circumvent p- glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1343-1347
34. Yeung K, Paterson I. Actin-binding marine macrolides: total synthesis and biological importance. Angew Chem Int Ed Engl 2002; 41: 4632-4653.
35. Patterson GML, Baldwin CL, Bolis CM, et al. Antineoplastic activity of cultured blue-green-algae (Cyanophyta). J Phycol 1991; 27: 530-536.
36. Patterson GML, Moore RE, Carmeli S, Smith CD, Kimura LH. Novel scytophycins and their manufacture and use as cytotoxic neoplasm inhibitors. U.S.A Patent 9306825, September 9, 1992.
37. Moore RE, Norton TR, Patterson GML, Mynderse JS, Furusawa E. Scytophycins. U.S.A Patent 205308, April 6, 1986.
38. Bubb MR, Spector I, Bershadsky AD, Korn ED. Swinholide A is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J Biol Chem 1995; 270: 3463-3466
39. Zhang X, Minale L, Zampella A, Smith CD. Microfilament depletion and circumvention of multiple drug resistance by sphinxolides. Cancer Res 1997; 57: 3751-3758.
40. Andrianasolo EH, Gross H, Goeger D, et al. Isolation of swinholide A and related glycosylated derivatives from two field collections of marine cyanobacteria. Org Lett 2005; 7: 1375-1378.
41. Degnan BM, Hawkins CJ, Lavin MF, McCaffrey EJ, Parry DL, Watters DJ. Novel cytotoxic compounds from the ascidian Lissoclinum bistratum. J Med Chem 1989; 32: 1354-1359.
42. Ishida K, Nakagawa H, Murakami M. Microcyclamide, a cytotoxic cyclic hexapeptide from the cyanobacterium Microcystis aeruginosa. J Nat Prod 2000; 63: 1315-1317.
43. Prinsep MR, Moore RE, Levine IA, Patterson GML. Westiellamide, a bistratamide-related cyclic peptide from the blue- green alga Westiellopsis prolifica. J Nat Prod 1992; 55: 140-142
44. Ogino J, Moore RE, Patterson GM, Smith CD. Dendroamides, new cyclic hexapeptides from a blue-green alga. multidrug-resistance reversing activity of dendroamide A. J Nat Prod 1996; 59: 581-6.
45. Ziemert N, Ishida K, Quillardet P, et al. Microcyclamide biosynthesis in two strains of Microcystis aeruginosa: from structure to genes and vice versa. Appl Environ Microbiol 2008; 74: 1791-7.
46. Rickards RW, Rothschild JM, Willis AC, et al. Calothrixins A and B, novel pentacyclic metabolites from Calothrix cyanobacteria with potent activity against malaria parasites and human cancer cells. Tetrahedron 1999; 55: 13513-13520.
47. Khan QA, Lu J, Hecht SM. Calothrixins, a new class of human DNA topoisomerase I poisons. J Nat Prod 2009; 72: page 442
48. von Elert E, Agrawal MK, Gebauer C, Jaensch H, Bauer U, Zitt A. Protease activity in gut Daphnia magna: evidence for trypsin and chymotrypsin enzymes. Comp Biochem Phys B Comp Biochem Phys B 2004; 137: 287-96.
49. Czarnecki O, Henning M, Lippert I, Welker M. Identification of peptide metabolites of Microcystis (Cyanobacteria) that inhibit trypsin-like activity in planktonic herbivorous Daphnia (Cladocera). Environ Microbiol 2006; 8: 77-87.
50. Rohrlack T, Christoffersen K, Friberg-Jensen U. Frequency of inhibitors of daphnid trypsin in the widely distributed cyanobacterial genus Planktothrix. Environ Microbiol 2005; 7: 1667-1669.
51. Chen L, Gui C, Luo X, et al. Cinanserin is an inhibitor of the 3C- like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 2005; 79: 7095-7103.
52. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 2004; 5: 417-421.
53. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989; 8: 3467-3475.
54. Ciechanover A, Iwai K. The ubiquitin system: from basic mechanisms to the patient bed. IUBMB Life 2004; 56: 193-201
55. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994; 79: 13-21.
56. Murakami M, Okita Y, Matsuda H, Okino T, Yamaguchi K. Aeruginosin 298-A, a thrombin and trypsin-inhibitor from the blue- green alga Microcystis aeruginosa (NIES-298). Tetrahedron Lett 1994; 35: 3129-3132.
57. Banker R, Carmeli S. Inhibitors of serine proteases from a waterbloom of the cyanobacterium Microcystis sp. Tetrahedron 1999; 55: 10835-10844.
58. Carroll AR, Pierens GK, Fechner G, et al. Dysinosin A: a novel inhibitor of factor VIIa and thrombin from a new genus and species of Australian sponge of the family Dysideidae. J Am Chem Soc. 2002; 124: 13340-1.
59. Carroll AR, Buchanan MS, Edser A, Hyde E, Simpson M, Quinn RJ. Dysinosins B-D, inhibitors of factor VIIa and thrombin from the Australian sponge Lamellodysidea chlorea. J Nat Prod 2004; 67: 1291-1294.
60. Hanessian S, Del Valle JR, Xue Y, Blomberg N. Total synthesis and structural confirmation of chlorodysinosin A. J Am Chem Soc 2006; 128: 10491-10495.
61. Hanessian S, Ersmark K, Wang X, et al. Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombin. Bioorg Med Chem Lett 2007; 17: 3480-3485.
62. Ersmark K, Del Valle JR, Hanessian S. Chemistry and biology of the aeruginosin family of serine protease inhibitors. Angew Chem Int Ed 2008; 47: 1202-1223.
63. Radau G, Gebel J, Rauh D. New cyanopeptide-derived low molecular weight thrombin inhibitors. Arch Pharm (Weinheim) 2003; 336: 372-380.
64. Sano T, Usui T, Ueda K, Osada H, Kaya K. Isolation of new protein phosphatase inhibitors from two cyanobacteria species, Planktothrix spp. J Nat Prod 2001; 64: 1052-1055.
65. Mehner C, Muller D, Kehraus S, Hautmann S, Gutschow M, Konig GM. New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase. ChemBioChem 2008; 9: 2692-2703.
66. Okino T, Qi S, Matsuda H, Murakami M, Yamaguchi K. Nostopeptins A and B, elastase inhibitors from the cyanobacterium Nostoc minutum. J Nat Prod 1997; 60: 158-161.
67. Plaza A, Bewley CA. Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp. J Org Chem 2006; 71: 6898-6907.
68. Matthew S, Ross C, Rocca JR, Paul VJ, Luesch H. Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides. J Nat Prod 2007; 70: 124-127.
69. Taori K, Matthew S, Rocca JR, Paul VJ, Luesch H. Lyngbyastatins 5-7, potent elastase inhibitors from floridian marine cyanobacteria, Lyngbya spp. J Nat Prod 2007; 70: 1593-1600.
70. Taori K, Paul VJ, Luesch H. Kempopeptins A and B, serine protease inhibitors with different selectivity profiles from a marine cyanobacterium, Lyngbya sp. J Nat Prod 2008; 71: 1625-1629
71. Matthew S, Ross C, Paul VJ, Luesch H. Pompanopeptins A and B, new cyclic peptides from the marine cyanobacterium Lyngbya confervoides. Tetrahedron 2008; 64: 4081-9.
72. Linington RG, Edwards DJ, Shuman CF, McPhail KL, Matainaho T, Gerwick WH. Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine cyanobacterium Symploca sp. J Nat Prod 2008; 71: 22-27.
73. Lee AY, Smitka TA, Bonjouklian R, Clardy J. Atomic structure of the trypsin-A90720A complex: a unified approach to structure and function. Chem Biol 1994; 1: 113-117.
74. Matern U, Schleberger C, Jelakovic S, Weckesser J, Schulz GE. Binding structure of elastase inhibitor scyptolin A. Chem Biol 2003; 10: 997-1001.
75. Ishitsuka MO, Kusumi T, Kakisawa H, Kaya K, Watanabe MM. Microviridin. A novel tricyclic depsipeptide from the toxic cyanobacterium Microcystis viridis. J Am Chem Soc 1990; 112: 8180-8182.
76. Okino T, Matsuda H, Murakami M, Yamaguchi K. New microviridins, elastase inhibitors from the blue-green alga Microcystis aeruginosa. Tetrahedron 1995; 51: 10679-10686
77. Fujii K, Sivonen K, Naganawa E, Harada K. Non-toxic peptides from toxic cyanobacteria, Oscillatoria agardhii. Tetrahedron 2000; 56: 725-33.
78. Murakami M, Sun Q, Ishida K, Matsuda H, Okino T, Yamaguchi K. Microviridins, elastase inhibitors from the cyanobacterium Nostoc minutum (NIES-26). Phytochemistry 1997; 45: 1197-1202.
79. Shin HJ, Murakami M, Matsuda H, Yamaguchi K. Microviridins D-F, serine protease inhibitors from the cyanobacterium Oscillatoria agardhii (NIES-204). Tetrahedron 1996; 52: 8159-68.
80. Ziemert N, Ishida K, Liaimer A, Hertweck C, Dittmann E. Ribosomal synthesis of tricyclic depsipeptides in bloom-forming cyanobacteria. Angew Chem Int Ed Engl 2008; 47: 7756-9.
81. Philmus B, Christiansen G, Yoshida WY, Hemscheidt TK. Post- translational modification in microviridin biosynthesis. ChemBioChem 2008; 9: 3066-73.
82. Schmidt EW, Harper MK, Faulkner DJ. Mozamides A and B, cyclic peptides from a Theonellid sponge from Mozambique. J Nat Prod 1997; 60: 779-82.
83. Kobayashi J, Sato M, Ishibashi M, Shigemori H, Nakamura T, Ohizumi Y. Keramamide A, a novel peptide from the Okinawan marine sponge Theonella sp. J Chem Soc, Perkin Trans 1 1991: 2609-11.
84. Kobayashi J, Sato M, Murayama T, et al. Konbamide, a novel peptide with calmodulin antagonistic activity from the Okinawan marine sponge Theonella sp. J Chem Soc, Chem Commun 1991: 1050-1052.
85. Uemoto H, Yahiro Y, Shigemori H, et al. Keramamides K and L, new cyclic peptides containing unusual tryptophan residue from Theonella sponge. Tetrahedron 1998; 54: 6719-24.
86. Kim DH, Kim YM, Li ZH, et al. A new type of carboxypeptidase A inhibitor: design, synthesis, and mechanistic implication. Pure Appl Chem 1994; 66: 721-728.
87. Bjoerquist P, Buchanan M, Campitelli M, et al. Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase U is beneficial, novel anabaenopeptin derivatives and intermediates thereof. U.S.A. Patent 2005039617, October 28, 2004.
88. Develter J, Dewilde M, Gils A, Declerck PJ. Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor. Thromb Haemost 2009; 102: 69-75.
89. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997; 78: 386-391.
90. Walther T, Renner S, Waldmann H, Arndt H. Synthesis and structure-activity correlation of a brunsvicamide-inspired cyclopeptide collection. ChemBioChem 2009; 10: 1153-62.
91. Okino T, Matsuda H, Murakami M, Yamaguchi K. Microginin, an angiotensin converting enzyme inhibitor from the blue-green alga Microcystis aeruginosa. Tetrahedron Lett 1993; 34: 501-4.
92. Neumann U, Forchert A, Flury T, Weckesser J. Microginin FR1, a linear peptide from a water bloom of Microcystis species. FEMS Microbiol Lett 1997; 153: 475-8.
93. Kodani S, Suzuki S, Ishida K, Murakami M. Five new cyanobacterial peptides from water bloom materials of lake Teganuma (Japan). FEMS Microbiol Lett 1999; 178: 343-8.
94. Ishida K, Kato T, Murakami M, Watanabe M, Watanabe MF. Microginins, zinc metalloproteases inhibitors from the cyanobacterium Microcystis aeruginosa. Tetrahedron 2000; 56: 8643-56.
95. Hall SL, Lorenc T. Secondary prevention of coronary artery disease. Am Fam Physician 2010; 81: 289-96.
96. Captopril approved for hypertension. FDA Drug Bull 1981; 11: 10- 11.
97. Gums JG. Use of ACE inhibitors in the treatment of cardiovascular disease. Am Pharm 1992; NS32: 62-70.
98. Hirsch CF, Liesch JM, Salvatore MJ, Schwartz RE, Sesin DF. Antifungal fermentation product. G.B. Patent 2220657, Jul 7, 1988.
99. Moore RE, Cheuk C, Patterson GML. Hapalindoles: new alkaloids from the blue-green alga Hapalosiphon fontinalis. J Am Chem Soc 1984; 106: 6456-7.
100. Mo S, Krunic A, Chlipala G, Orjala J. Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. J Nat Prod 2009; 72: 894-9.
101. Richter JM, Ishihara Y, Masuda T, et al. Enantiospecific total synthesis of the hapalindoles, fischerindoles, and welwitindo- linones via a redox economic approach. J Am Chem Soc 2008; 130: 17938-54.
102. Doan NT, Stewart PR, Smith GD. Inhibition of bacterial RNA polymerase by the cyanobacterial metabolites 12-epi-hapalindole E isonitrile and calothrixin A. FEMS Microbiol Lett 2001; 196: 135- 9.
103. Huber U, Moore RE, Patterson GML. Isolation of a nitrile- containing indole alkaloid from the terrestrial blue-green alga Hapalosiphon delicatulus. J Nat Prod 1998; 61: 1304-6.
104. Klein D, Daloze D, Braekman JC, Hoffmann L, Demoulin V. New hapalindoles from the cyanophyte Hapalosiphon laingii. J Nat Prod 1995; 58: 1781-5
105. Moore RE, Cheuk C, Yang XQG, et al. Hapalindoles, antibacterial and antimycotic alkaloids from the cyanophyte Hapalosiphon fontinalis. J Org Chem 1987; 52: 1036-43.
106. Moore RE, Yang XG, Patterson GML, Bonjouklian R, Smitka TA. Hapalonamides and other oxidized hapalindoles from Hapalosiphon fontinalis. Phytochemistry 1989; 28: 1565-7
107. Park A, Moore RE, Patterson GML. Fischerindole L, a new isonitrile from the terrestrial blue-green alga Fischerella muscicola. Tetrahedron Lett 1992; 33: 3257-60.
108. Jimenez JI, Huber U, Moore RE, Patterson GML. Oxidized welwitindolinones from terrestrial Fischerella spp. J Nat Prod 1999; 62: 569-72.
109. Stratmann K, Moore RE, Bonjouklian R, et al. Welwitindolinones, unusual alkaloids from the blue-green algae Hapalosiphon welwitschii and Westiella intricata. Relationship to fischerindoles and hapalinodoles. J Am Chem Soc 1994; 116: 9935-42
110. Raveh A, Carmeli S. Antimicrobial ambiguines from the cyanobacterium Fischerella sp. collected in Israel. J Nat Prod 2007; 70: 196-201.
111. Smitka TA, Bonjouklian R, Doolin L, et al. Ambiguine isonitriles, fungicidal hapalindole-type alkaloids from three genera of blue- green algae belonging to the Stigonemataceae. J Org Chem 1992; 57: 857-61.
112. Bonjouklian R, Moore RE, Patterson GML, Smitka TA. Preparation of hapalindole-related alkaloids from blue-green algae. U.S.A. Patent 5292650, September 16, 1992.
113. Bonjouklian R, Moore RE, Patterson GML, Smitka TA. A89271 factors and processes for their production. U.S.A. Patent 5457119, October 10, 1995.
114. Moore RE, Patterson GML. Hapalindoles. U.S.A. Patent 4755610, July 5, 1988.
115. Ravi KA, Arunima S, Akhilesh PS, et al. Identification of an antimicrobial entity from the cyanobacterium Fischerella sp. isolated from bark of Azadirachta indica (Neem) tree. J Appl Phycol 2006; 18: 33-9.
116. Bonjouklian R, Smitka TA, Doolin LE, et al. Tjipanazoles, new antifungal agents from the blue-green alga Tolypothrix tjipanasensis. Tetrahedron 1991; 47: 7739-50.
117. Wright AD, Papendorf O, Koig GM. Ambigol C and 2,4- dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua. J Nat Prod 2005; 68: 459-61.
118. Guo S, Tipparaju SK, Pegan SD, et al. Natural product leads for drug discovery: Isolation, synthesis and biological evaluation of 6- cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents. Bioorg Med Chem 2009; 17: 7126-30.
119. Knübel G, Larsen LK, Moore RE, Levine IA, Patterson GML. Cytotoxic, antiviral indolocarbazoles from a blue-green alga belonging to the Nostocaceae. J Antibiot (Tokyo) 1990; 43: 1236- 9.
120. Becher PG, Beuchat J, Gademann K, Juttner F. Nostocarboline: Isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. J Nat Prod 2005; 68: 1793-5.
121. Blom JF, Brutsch T, Barbaras D, et al. Potent algicides based on the cyanobacterial alkaloid nostocarboline. Org Lett 2006; 8: 737- 40.
122. Barbaras D, Kaiser M, Brun R, Gademann K. Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarbo- line and its dimers. Bioorg Med Chem Lett 2008; 18: 4413-5.
123. Schlegel I, Doan N, de Chazal N, Smith G. Antibiotic activity of new cyanobacterial isolates from Australia and Asia against green algae and cyanobacteria. J Appl Phycol 1998; 10: 471-9.
124. Hagmann L, Jütner F. Fischerellin A, a novel photosystem-II- inhibiting allelochemical of the cyanobacterium Fischerella muscicola with antifungal and herbicidal activity. Tetrahedron Lett 1996; 37: 6539-42.
125. Papke U, Gross EM, Francke W. Isolation, identification and determination of the absolute configuration of Fischerellin B. A new algicide from the freshwater cyanobacterium Fischerella muscicola (Thuret). Tetrahedron Lett 1997; 38: 379-82.
126. Kajiyama S, Kanzaki H, Kawazu K, Kobayashi A. Nostofungicidine, an antifungal lipopeptide from the field-grown terrestrial blue-green alga Nostoc commune. Tetrahedron Lett 1998; 39: 3737-40.
127. Moon SS, Chen J, Moore RE, Patterson GML. Calophycin, a fungicidal cyclic decapeptide from the terrestrial blue-green alga Calothrix fusca. J Org Chem 1992; 57: 1097-103.
128. Neuhof T, Schmieder P, Preussel K, et al. Hassallidin A, a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp. J Nat Prod 2005; 68: 695-700.
129. Neuhof T, Schmieder P, Seibold M, Preussel K, von Döhren H. Hassallidin B -second antifungal member of the Hassallidin family. Bioorg Med Chem Lett 2006; 16: 4220-2.
130. Muller D, Krick A, Kehraus S, et al. Brunsvicamides A-C: sponge- related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity. J Med Chem 2006; 49: 4871-8.
131. Prinsep MR, Thomson RA, West ML, Wylie BL. Tolypodiol, an antiinflammatory diterpenoid from the cyanobacterium Tolypothrix nodosa. J Nat Prod 1996; 59: 786-8.
132. Jaki B, Orjala J, Sticher O. A novel extracellular diterpenoid with antibacterial activity from the cyanobacterium Nostoc commune. J Nat Prod 1999; 62: 502-3.
133. Jaki B, Orjala J, Heilmann J, Linden A, Vogler B, Sticher O. Novel extracellular diterpenoids with biological activity from the cyanobacterium Nostoc commune. J Nat Prod 2000; 63: 339-43.
134. Pérez Gutiérrez R, Martínez Flores A, Vargas Solís R, Carmona Jimenez J. Two new antibacterial norabietane diterpenoids from cyanobacteria, Microcoleous lacustris. J Nat Med 2008; 62: 328-31.
135. Mo S, Krunic A, Pegan SD, Franzblau SG, Orjala J. An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. J Nat Prod 2009; 72: 2043-5.
136. Clardy J, Walsh C. Lessons from natural molecules. Nature 2004; 432: 829-37.
137. Carmichael WW. Cyanobacteria secondary metabolites - the cyanotoxins. J Appl Bacteriol 1992; 72: 445-59.
138. Olaizola M. Commercial development of microalgal biotechnology: from the test tube to the marketplace. Biomol Eng 2003; 20: 459-66.
139. Ehrenreich IM, Waterbury JB, Webb EA. Distribution and diversity of natural product genes in marine and freshwater cyanobacterial cultures and genomes. Appl Environ Microbiol 2005; 71: 7401-13.
140. Barrios-Llerena ME, Burja AM, Wright PC. Genetic analysis of polyketide synthase and peptide synthetase genes in cyanobacteria as a mining tool for secondary metabolites. J Ind Microbiol Biotechnol 2007; 34: 443-56.
141. Kalaitzis JA, Lauro FM, Neilan BA. Mining cyanobacterial genomes for genes encoding complex biosynthetic pathways. Nat Prod Rep 2009; 26: 1447-65.
142. Molinski TF. Nanomole-scale natural products discovery. Curr Opin Drug Discov Devel 2009; 12: 197-206.
143. Jaki B, Heilmann J, Sticher O. New antibacterial metabolites from the cyanobacterium Nostoc commune (EAWAG 122b). J Nat Prod 2000; 63: 1283-5.
144. Volk RB, Furkert FH. Antialgal, antibacterial and antifungal activity of two metabolites produced and excreted by cyanobacteria during growth. Microbiol Res 2006; 161: 180-6.
145. Namikoshi M, Carmichael WW, Sakai R, Jareserijman EA, Kaup AM, Rinehart KL. 9-deazaadenosine and its 5'-alpha-d- glucopyranoside isolated from the cyanobacterium Anabaena affinis strain VS-1. J Am Chem Soc 1993; 115: 2504-5.
146. Bonjouklian R, Smitka TA, Hunt AH, et al. A90720A, a serine protease inhibitor isolated from a terrestrial blue-green alga Microchaete loktakensis. Tetrahedron 1996; 52: 395-404.
147. Portmann C, Blom JF, Gademann K, Juttner F. Aerucyclamides A and B: Isolation and synthesis of toxic ribosomal heterocyclic peptides from the cyanobacterium Microcystis aeruginosa PCC 7806. J Nat Prod 2008; 71: 1193-6.
148. Ishida K, Matsuda H, Okita Y, Murakami M. Aeruginoguanidines 98-A-98-C: cytotoxic unusual peptides from the cyanobacterium Microcystis aeruginosa. Tetrahedron 2002; 58: 7645-52.
149. Harada K, Mayumi T, Shimada T, et al. Co-production of microcystins and aeruginopeptins by natural cyanobacterial bloom. Environ Toxicol 2001; 16: 298-305.
150. Harada K, Mayumi T, Shimada T, Suzuki M, Kondo F, Watanabe MF. Occurrence of four depsipeptides, aeruginopeptins, together with microcystins from toxic cyanobacteria. Tetrahedron Lett 1993; 34: 6091-4.
151. Ishida K, Okita Y, Matsuda H, Okino T, Murakami M. Aeruginosins, protease inhibitors from the cyanobacterium Microcystis aeruginosa. Tetrahedron 1999; 55: 10971-88.
152. Matsuda H, Okino T, Murakami M, Yamaguchi K. Aeruginosins 102-A and B, new thrombin inhibitors from the cyanobacterium Microcystis viridis (NIES-102). Tetrahedron 1996; 52: 14501-6.
153. Kodani S, Ishida K, Murakami M. Aeruginosin 103-A, a thrombin inhibitor from the cyanobacterium Microcystis viridis. J Nat Prod 1998; 61: 1046-8.
154. Shin HJ, Matsuda H, Murakami M, Yamaguchi K. Aeruginosins 205A and -B, Serine Protease Inhibitory Glycopeptides from the Cyanobacterium Oscillatoria agardhii (NIES-205). J Org Chem 1997; 62: 1810-3.
155. Murakami M, Ishida K, Okino T, Okita Y, Matsuda H, Yamaguchi K. Aeruginosin 98-A and aeruginosin 98-B, trypsin-inhibitors from the blue-green-alga Microcystis aeruginosa (NIES-98). Tetrahedron Lett 1995; 36: 2785-8.
156. Ploutno A, Shoshan M, Carmeli S. Three novel protease inhibitors from a natural bloom of the cyanobacterium Microcystis aeruginosa. J Nat Prod 2002; 65: 973-8.
157. Raveh A, Carmeli S. Two novel biological active modified peptides from the cyanobacterium Microcystis sp. Phytochemistry Lett 2009; 2: 10-4.
158. Shin HJ, Matsuda H, Murakami M, Yamaguchi K. Agardhipeptins A and B, two new cyclic hepta- and octapeptide, from the cyanobacterium Oscillatoria agardhii (NIES-204). Tetrahedron 1996; 52: 13129-36.
159. Falch BS, König GM, Wright AD, Sticher O, Ruegger H, Bernardinelli G. Ambigol A and B: new biologically active polychlorinated aromatic compounds from the terrestrial blue-green alga Fischerella ambigua. J Org Chem 1993; 58: 6570-75.
160. Falch BS, König GM, Wright AD, et al. Biological-activities of cyanobacteria - evaluation of extracts and pure compounds. Planta Med 1995; 61: 321-8.
161. Fujii K, Harada K, Suzuki M, et al. Novel cyclic peptides together with microcystins produced by toxic cyanobacteria, Anabaena sp. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 1995; 37: 445-50.
162. Fujii K, Sivonen K, Nakano T, Harada K. Structural elucidation of cyanobacterial peptides encoded by peptide synthetase gene in Anabaena species. Tetrahedron 2002; 58: 6863-71.
163. Okumura HS, Philmus B, Portmann C, Hemscheidt TK. Homotyrosine-Containing Cyanopeptolins 880 and 960 and Anabaenopeptins 908 and 915 from Planktothrix agardhii CYA 126/8. J Nat Prod 2009; 72: 172-6.
164. Harada K, Fujii K, Shimada T, et al. Two cyclic peptides, anabaenopeptins, a third group of bioactive compounds from the cyanobacterium Anabaena flos-aquae NRC 525-17. Tetrahedron Lett 1995; 36: 1511-4.
165. Murakami M, Shin HJ, Matsuda H, Ishida K, Yamaguchi K. A cyclic peptide, anabaenopeptin B, from the cyanobacterium Oscillatoria agardhii. Phytochemistry 1997; 44: 449-52.
166. Shin HJ, Matsuda H, Murakami M, Yamaguchi K. Anabaenopeptins E and F, two new cyclic peptides from the cyanobacterium Oscillatoria agardhii (NIES-204). J Nat Prod 1997; 60: 139-41.
167. Itou Y, Suzuki S, Ishida K, Murakami M. Anabaenopeptins G and H, potent carboxypeptidase A inhibitors from the cyanobacterium Oscillatoria agardhii (NIES-595). Bioorg Med Chem Lett 1999; 9: 1243-6.
168. Gesner-Apter S, Carmeli S. Protease inhibitors from a water bloom of the cyanobacterium Microcystis aeruginosa. J Nat Prod 2009; 72: 1429-36.
169. Shin HJ, Matsuda H, Murakami M, Yamaguchi K. Anabaenopeptins C and D, two new cyclic peptides from the cyanobacterium Oscillatoria agardhii (NIES-204). J Nat Prod 1997; 60: 139-41.
170. Grach-Pogrebinsky O, Carmeli S. Three novel anabaenopeptins from the cyanobacterium Anabaena sp. Tetrahedron 2008; 64: 10233-38.
171. Banker R, Carmeli S. Tenuecyclamides A-D, cyclic hexapeptides from the cyanobacterium Nostoc spongiaeforme var. tenue. J Nat Prod 1998; 61: 1248-51.
172. Hemscheidt T, Puglisi MP, Larsen LK, et al. Structure and biosynthesis of borophycin, a new boeseken complex of boric acid from a marine strain of the blue-green alga Nostoc linckia. J Org Chem 1994; 59: 3467-71.
173. Sisay MT, Hautmann S, Mehner C, Konig GM, Bajorath J, Gutschow M. Inhibition of human leukocyte elastase by brunsvicamides A-C: cyanobacterial cyclic peptides. ChemMedChem 2009; 4: 1425-9.
174. Bui HTN, Jansen R, Pham HTL, Mundt S. Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp. J Nat Prod 2007; 70: 499-503.
175. Mundt S, Kreitlow S, Jansen R. Fatty acids with antibacterial activity from the cyanobacterium Oscillatoria redekei HUB 051. J Appl Phycol 2003; 15: 263-7.
176. Chuan S, Teicher BA. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides. Curr Pharm Des 2001; 7: 1259-76.
177. Lee EJ, Gleason FK. A second algicidal natural product from the cyanobacterium, Scytonema hofmanni. Plant Sci 1994; 103: 155-60.
178. Pignatello JJ, Porwoll J, Carlson RE, Xavier A, Gleason FK, Wood JM. Structure of the antibiotic cyanobacterin, a chlorine-containing γ-lactone from the freshwater cyanobacterium Scytonema hofmanni. J Org Chem 1983; 48: 4035-8.
179. von Elert E, Oberer L, Merkel P, Huhn T, Blom JF. Cyanopeptolin 954, a chlorine-containing chymotrypsin inhibitor of Microcystis aeruginosa NIVA CYA 43. J Nat Prod 2005; 68: 1324-7.
180. Bister B, Keller S, Baumann HI, et al. Cyanopeptolin 963A, a chymotrypsin inhibitor of Microcystis PCC 7806. J Nat Prod 2004; 67: 1755-7.
181. Welker M, Brunke M, Preussel K, Lippert I, von Dohren H. Diversity and distribution of Microcystis (Cyanobacteria) oligopeptide chemotypes from natural communities studied by single-colony mass spectrometry. Microbiol 2004; 150: 1785-96.
182. Choi H, Oh SK, Yih W, Chin J, Kang H, Rho JR. Cyanopeptoline CB071: a cyclic depsipeptide isolated from the freshwater cyanobacterium Aphanocapsa sp. Chem Pharm Bull (Tokyo) 2008; 56: 1191-3.
183. Jakobi C, Oberer L, Quiquerez C, König WA, Weckesser J. Cyanopeptolin S, a sulfate-containing depsipeptide from a water bloom of Microcystis sp. FEMS Microbiol Lett 1995; 129: 129-33.
184. Martin C, Oberer L, Ino T, Koenig WA, Busch M, Weckesser J. Cyanopeptolins, new depsipeptides from the cyanobacterium Microcystis sp. PCC 7806. J. Antibiot 1993; 46: 1550-6.
185. Sano T, Takagi H, Morrison LF, Metcalf JS, Codd GA, Kaya K. Leucine aminopeptidase M inhibitors, cyanostatin A and B, isolated from cyanobacterial water blooms in Scotland. Phytochemistry (Amsterdam) 2005; 66: 543-8.
186. Moore BS, Chen J, Patterson GML, et al.[7.7]paracyclophanes from blue-green algae. J Am Chem Soc. 1990; 112: 4061-3.
187. Moore BS, Chen J, Patterson GML, Moore RE. Structures of cylindrocyphanes A-F. Tetrahedron 1992; 48: 3001-6.
188. Kodani S, Ishida K, Murakami M. Dehydroradiosumin, a trypsin inhibitor from the cyanobacterium Anabaena cylindrica. J Nat Prod 1998; 61: 854-6.
189. ] Williams DE, Craig M, Holmes CFB, Andersen RJ. Ferintoic acids A and B, new cyclic hexapeptides from the freshwater cyanobacterium Microcystis aeruginosa. J Nat Prod 1996; 59: 570- 5.
190. Matern U, Oberer L, Erhard M, Herdman M, Weckesser J. Hofmannolin, a cyanopeptolin from Scytonema hofmanni PCC 7110. Phytochemistry 2003; 64: 1061-7.
191. Zainuddin EN, Mentel R, Wray V, et al. Cyclic depsipeptides, ichthyopeptins A and B, from Microcystis ichthyoblabe. J Nat Prod 2007; 70: 1084-8.
192. Ishida K, Matsuda H, Murakami M, Yamaguchi K. Kawaguchipeptin B, A antibacterial cyclic undecapeptide from the cyanobacterium Microcystis aeruginosa. J Nat Prod 1997; 60: 724- 6.
193. Bonnard I, Rolland M, Francisco C, Banaigs B. Total structure and biological properties of laxaphycins A and B, cyclic lipopeptides from the marine cyanobacterium Lyngbya majuscula. Lett Peptide Sci 1997; 4: 289-92.
194. Frankmölle WP, Larsen LK, Caplan FR, et al. Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. I. isolation and biological properties. J Antibiot (Tokyo) 1992; 45: 1451-7.
195. Frankmölle WP, Knübel G, Moore RE, Patterson GM. Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. II. structures of laxaphycins A, B, D and E. J Antibiot (Tokyo) 1992; 45: 1458-66.
196. Tsukamoto S, Painuly P, Young KA, Yang X, Shimizu Y, Cornell L. Microcystilide A: a novel cell-differentiation-promoting depsipeptide from Microcystis aeruginosa NO-15-1840. J Am Chem Soc 1993; 115: 11046-7.
197. Welker M, Marsalek B, Sejnohova L, von Doehren H. Detection and identification of oligopeptides in Microcystis (cyanobacteria) colonies: Toward an understanding of metabolic diversity. Peptides (New York) 2006; 27: 2090-103.
198. Gesner-Apter S, Carmeli S. Three novel metabolites from a bloom of the cyanobacterium Microcystis sp. Tetrahedron 2008; 64: 6628- 34.
199. Reshef V, Carmeli S. Protease inhibitors from a water bloom of the cyanobacterium Microcystis aeruginosa. Tetrahedron 2001; 57: 2885-94.
200. Ishida K, Matsuda H, Murakami M, Yamaguchi K. Microginins 299-A and -B, leucine aminopeptidase inhibitors from the cyanobacterium Microcystis aeruginosa (NIES-299). Tetrahedron 1997; 53: 10281-8.
201. Ishida K, Matsuda H, Murakami M. Four new microginins, linear peptides from the cyanobacterium Microcystis aeruginosa. Tetrahedron 1998; 54: 13475-84.
202. Murakami M, Kodani S, Ishida K, Matsuda H, Yamaguchi K. Micropeptin 103, a chymotrypsin inhibitor from the cyanobacterium Microcystis viridis (NIES-103). Tetrahedron Lett 1997; 38: 3035-8.
203. Ishida K, Matsuda H, Murakami M, Yamaguchi K. Micropeptins 478-A and B, Plasmin Inhibitors from the Cyanobacterium Microcystis aeruginosa. J Nat Prod. 1997; 60: 184-7.
204. Ishida K, Matsuda H, Murakami M. Micropeptins 88-A to 88-F, chymotrypsin inhibitors from the cyanobacterium Microcystis aeruginosa (NIES-88). Tetrahedron 1998; 54: 5545-56.
205. Yamaki H, Sitachitta N, Sano T, Kaya K. Two new chymotrypsin inhibitors isolated from the cyanobacterium Microcystis aeruginosa NIES-88. J Nat Prod 2005; 68: 14-8.
206. Ishida K, Murakami M, Matsuda H, Yamaguchi K. Micropeptin 90, a plasmin and trypsin inhibitor from the blue-green alga Microcystis aeruginosa (NIES-90). Tetrahedron Lett 1995; 36: 3535-8.
207. Okino T, Murakami M, Haraguchi R, Munekata H, Matsuda H, Yamaguchi K. Micropeptins A and B, plasmin and trypsin inhibitors from the blue-green alga Microcystis aeruginosa. Tetrahedron Lett 1993; 34: 8131-4.
208. Kisugi T, Okino T. Micropeptins from the freshwater cyanobacterium Microcystis aeruginosa (NIES-100). J Nat Prod 2009; 72: 777-81.
209. Zafrir E, Carmeli S. Micropeptins from an Israeli fishpond water bloom of the cyanobacterium Microcystis sp. J Nat Prod 2010; 73: 352-8.
210. Okano T, Sano T, Kaya K. Micropeptin T-20, a novel phosphate- containing cyclic depsipeptide from the cyanobacterium Microcystis aeruginosa. Tetrahedron Lett 1999; 40: 2379-82.
211. Rohrlack T, Christoffersen K, Hansen PE, et al. Isolation, characterization, and quantitative analysis of Microviridin J, a new Microcystis metabolite toxic to Daphnia. J.Chem Ecol 2003; 29: 1757-70.
212. Reshef V, Carmeli S. New microviridins from a water bloom of the cyanobacterium Microcystis aeruginosa. Tetrahedron 2006; 62: 7361-9.
213. Carmeli S, Moore RE, Patterson GML, Mori Y, Suzuki M. Isonitriles from the blue-green alga Scytonema mirabile. J Org Chem 1990; 55: 4431-8.
214. Carmeli S, Moore RE, Patterson GML. Mirabimides A-D, new N- acylpyrrolinones from the blue-green alga Scytonema mirabile. Tetrahedron 1991; 47: 2087-96.
215. Paik SG, Carmeli S, Cullingham J, Moore RE, Patterson GML, Tius MA. Mirabimide-E, an unusual N-acylpyrrolinone from the blue-green alga Scytonema mirabile - structure determination and synthesis. J Am Chem Soc 1994; 116: 8116-25.
216. Nagatsu A, Kajitani H, Sakakibara J. Muscoride A: A new oxazole peptide alkaloid from freshwater cyanobacterium Nostoc muscorum. Tetrahedron Lett 1995; 36: 4097-100.
217. Fujii K, Sivonen K, Adachi K, et al. Comparative study of toxic and non-toxic cyanobacterial products: novel peptides from toxic Nodularia spumigena AV1. Tetrahedron Lett 1997; 38: 5525-8.
218. Becher PG, Baumann HI, Gademann K, Juettner F. The cyanobacterial alkaloid nostocarboline: an inhibitor of acetylcholinesterase and trypsin. J Appl Phycol 2009; 21: 103-10.
219. Hirata K, Yoshitomi S, Dwi S, et al. Bioactivities of nostocine a produced by a freshwater cyanobacterium Nostoc spongiaeforme TISTR 8169. J Biosci Bioeng 2003; 95: 512-7.
220. Kaya K, Sano T, Beattie KA, Codd GA. Nostocyclin, a novel 3- amino-6-hydroxy-2-piperidone-containing cyclic depsipeptide from the cyanobacterium Nostoc sp. Tetrahedron Lett 1996; 37: 6725-8.
221. Golakoti T, Yoshida WY, Chaganty S, Moore RE. Isolation and structure determination of nostocyclopeptides A1 and A2 from the terrestrial cyanobacterium Nostoc sp. ATCC53789. J Nat Prod 2001; 64: 54-9
222. Chen J, Moore RE, Patterson GML. Structures of nostocyclophanes A-D. J Org Chem 1991; 56: 4360-4.
223. Ploutno A, Carmeli S. Nostocyclyne A, a novel antimicrobial cyclophane from the cyanobacterium Nostoc sp. J Nat Prod 2000; 63: 1524-6.
224. Ploutno A, Carmeli S. Modified peptides from a water bloom of the cyanobacterium Nostoc sp. Tetrahedron 2002; 58: 9949-57.
225. Sano T, Kaya K. A 3-amino-10-chloro-2-hydroxydecanoic acid- containing tetrapeptide from Oscillatoria agardhii. Phytochemistry 1997; 44: 1503-5.
226. Sano T, Kaya K. Oscillamide Y, a chymotrypsin inhibitor from toxic Oscillatoria agardhii. Tetrahedron Lett 1995; 36: 5933-6.
227. Shin HJ, Murakami M, Matsuda H, Ishida K, Yamaguchi K. Oscillapeptin, an elastase and chymotrypsin inhibitor from the cyanobacterium Oscillatoria agardhii (NIES-204). Tetrahedron Lett 1995; 36: 5235-8.
228. Itou Y, Ishida K, Shin HJ, Murakami M. Oscillapeptins A to F, serine protease inhibitors from the three strains of Oscillatoria agardhii. Tetrahedron 1999; 55: 6871-82.
229. Sano T, He J, Liu Y, Kaya K. Isolation of bioactive compounds in cyanobacteria from Chinese fresh water. 1. trypsin inhibitor. Phycol Res 1998; 46: 13-17.
230. Blom JF, Bister B, Bischoff D, Nicholson G, Jung G, Sussmuth RD, Juttner F. Oscillapeptin J, a new grazer toxin of the freshwater cyanobacterium Planktothrix rubescens. J Nat Prod 2003; 66: 431- 4.
231. An T, Kumar TKS, Wang M, et al. Structures of pahayokolides A and B, cyclic peptides from a Lyngbya sp. J Nat Prod 2007; 70: 730-5.
232. Berry JP, Gantar M, Gawley RE, Wang M, Rein KS. Pharmacology and toxicology of pahayokolide A, a bioactive metabolite from a freshwater species of Lyngbya isolated from the Florida Everglades. Comp Biochem and Physiol C Toxicol Pharmacol 2004; 139: 231-8.
233. Grach-Pogrebinsky O, Sedmak B, Carmeli S. Protease inhibitors from a Slovenian lake Bled toxic waterbloom of the cyanobacterium Planktothrix rubescens. Tetrahedron 2003; 59: 8329-36.
234. Baumann HI, Keller S, Wolter FE, et al. Planktocyclin, a cyclooctapeptide protease inhibitor produced by the freshwater cyanobacterium Planktothrix rubescens. J Nat Prod 2007; 70: 1611-5.
235. Reshef V, Carmeli S. Schizopeptin 791, a new anabeanopeptin-like cyclic peptide from the cyanobacterium Schizothrix sp. J Nat Prod 2002; 65: 1187-9.
236. Pergament I, Carmeli S. Schizotrin A; a novel antimicrobial cyclic peptide from a cyanobacterium. Tetrahedron Lett 1994; 35: 8473-6.
237. Matern U, Oberer L, Falchetto RA, et al. Scyptolin A and B, cyclic depsipeptides from axenic cultures of Scytonema hofmanni PCC 7110. Phytochemistry 2001; 58: 1087-95.
238. Proteau PJ, Gerwick WH, Garcia-Pichel F, Castenholz RW. The structure of scytonemin, an ultraviolet sunscreen pigment from the sheaths of cyanobacteria. Experientia 1993; 49: 825-9.
239. Helms GL, Moore RE, Niemczura WP, Patterson GML, Tomer KB, Gross ML. Scytonemin A, a novel calcium antagonist from a blue-green alga. J Org Chem 1988; 53: 1298-307.
240. Kaya K, Mahakhant A, Keovara L, Sano T, Kubo T, Takagi H. Spiroidesin, a novel lipopeptide from the cyanobacterium Anabaena spiroides that inhibits cell growth of the cyanobacterium Microcystis aeruginosa. J Nat Prod 2002; 65: 920-1.
241. Ozdemir G, Karabay NU, Dalay MC, Pazarbasi B.Antibacterial activity of volatile component and various extracts of Spirulina platensis. Phytother. Res. 2004; 18: 754-7.
242. Jaki B, Zerbe O, Heilmann J, Sticher O. Two novel cyclic peptides with antifungal activity from the cyanobacterium Tolypothrix byssoidea (EAWAG 195). J Nat Prod 2001; 64: 154-8.
243. Prinsep MR, Caplan FR, Moore RE, Patterson GML, Smith CD. Tolyporphin, a novel multidrug resistance reversing agent from the blue-green alga Tolypothrix nodosa. J Am Chem Soc 1992; 114: 385-7.
244. Prinsep MR, Patterson GML, Larsen LK, Smith CD. Further tolyporphins from the blue-green alga Tolypothrix nodosa. Tetrahedron 1995; 51: 10523-30.
245. Prinsep MR, Patterson GM, Larsen LK, Smith CD. Tolyporphins J and K, two further porphinoid metabolites from the cyanobacterium Tolypothrix nodosa. J Nat Prod 1998; 61: 1133-6.
246. Stewart JB, Bornemann V, Chen JL, et al. Cyto-toxic, fungicidal nucleosides from blue-green algae belonging to the Scytonemataceae. J.Antibiot. 1988; 41: 1048-56.
247. Mehner C, Muller D, Krick A, et al. A novel beta-amino acid in cytotoxic peptides from the cyanobacterium Tychonema sp. Eur J Org Chem 2008: 1732-9